With growth in percutaneous fixes for the valve, surgeons at STS 2025 called for innovation, team-based care, and more data.
Boston Scientific Corporation ( NYSE: BSX) Q4 2024 Earnings Conference Call February 5, 2025 8:00 AM ET Jonathan Monson - SVP, IR Michael Mahoney - Chairman and CEO Daniel Brennan - EVP and CFO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback